Published in Proc Natl Acad Sci U S A on June 21, 2010
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature (2011) 4.34
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest (2011) 4.21
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 3.78
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation (2012) 3.38
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A (2011) 3.35
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci U S A (2010) 3.00
Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem (2010) 2.99
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov (2012) 2.65
SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab (2011) 2.29
MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology (2012) 2.15
Inhibition of microRNA function by antimiR oligonucleotides. Silence (2012) 2.02
Adult-specific functions of animal microRNAs. Nat Rev Genet (2013) 1.89
MicroRNAs in lipid metabolism. Curr Opin Lipidol (2011) 1.79
MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice. J Am Heart Assoc (2012) 1.63
Development of microRNA therapeutics is coming of age. EMBO Mol Med (2014) 1.60
Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle (2012) 1.60
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med (2012) 1.54
MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol (2011) 1.54
microRNAs and cholesterol metabolism. Trends Endocrinol Metab (2010) 1.49
An overview of microRNAs. Adv Drug Deliv Rev (2015) 1.48
The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2. Arterioscler Thromb Vasc Biol (2015) 1.45
Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab (2013) 1.42
MicroRNAs and cardiovascular diseases. FEBS J (2011) 1.41
Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2013) 1.38
MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression. Exp Neurol (2011) 1.38
MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med (2013) 1.34
MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol (2013) 1.33
The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr (2011) 1.30
MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor. Circ Res (2013) 1.30
Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report. Arterioscler Thromb Vasc Biol (2013) 1.28
MicroRNA therapeutics in cardiovascular medicine. EMBO Mol Med (2011) 1.28
Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ Res (2013) 1.25
Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis (2012) 1.24
A CHOP-regulated microRNA controls rhodopsin expression. J Cell Biol (2011) 1.22
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat Commun (2013) 1.22
MicroRNAs and liver disease. Transl Res (2011) 1.21
MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb Symp Quant Biol (2011) 1.21
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med (2013) 1.21
A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol (2013) 1.21
An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab (2013) 1.20
MicroRNA 33 regulates glucose metabolism. Mol Cell Biol (2013) 1.19
Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J (2011) 1.18
miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes (2012) 1.16
MicroRNA modulation of cholesterol homeostasis. Arterioscler Thromb Vasc Biol (2011) 1.14
DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet (2015) 1.12
Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci (2015) 1.11
MicroRNA Regulation of Atherosclerosis. Circ Res (2016) 1.10
Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells. Biochim Biophys Acta (2011) 1.09
Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. Nat Med (2015) 1.07
Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken. PLoS One (2013) 1.06
MicroRNAs regulating lipid metabolism in atherogenesis. Thromb Haemost (2012) 1.06
Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. EMBO Mol Med (2014) 1.04
A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med (2012) 1.03
MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest (2015) 1.03
Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis (2013) 1.02
MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes. Diabetes (2014) 1.01
MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond) (2014) 0.98
MicroRNAs in metabolism. Acta Physiol (Oxf) (2016) 0.97
Spatial distribution of the pathways of cholesterol homeostasis in human retina. PLoS One (2012) 0.95
MicroRNA therapeutics: Discovering novel targets and developing specific therapy. Perspect Clin Res (2016) 0.94
The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities. J Biol Chem (2013) 0.94
MicroRNA control of high-density lipoprotein metabolism and function. Circ Res (2014) 0.93
MiR-103 controls milk fat accumulation in goat (Capra hircus) mammary gland during lactation. PLoS One (2013) 0.93
Roles of microRNAs in atherosclerosis and restenosis. J Biomed Sci (2012) 0.93
Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis. Adv Exp Med Biol (2015) 0.92
Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33. Circ Res (2014) 0.92
Eyeballing cholesterol efflux and macrophage function in disease pathogenesis. Trends Endocrinol Metab (2013) 0.92
Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis. Circ Res (2015) 0.92
Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus. Cell Metab (2011) 0.90
Inhibition of atherosclerosis-promoting microRNAs via targeted polyelectrolyte complex micelles. J Mater Chem B Mater Biol Med (2014) 0.90
Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies. Nutr Metab (Lond) (2012) 0.90
MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis (2012) 0.90
MicroRNAs and atherosclerosis. Curr Atheroscler Rep (2013) 0.89
Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention. Metabolites (2013) 0.89
Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects. Nat Commun (2016) 0.89
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med (2013) 0.88
Post-transcriptional regulation in metabolic diseases. RNA Biol (2012) 0.88
MicroRNA Regulation of Cholesterol Metabolism. Cholesterol (2012) 0.88
HDL, Atherosclerosis, and Emerging Therapies. Cholesterol (2013) 0.87
Therapeutic Action of Fluoxetine is Associated with a Reduction in Prefrontal Cortical miR-1971 Expression Levels in a Mouse Model of Posttraumatic Stress Disorder. Front Psychiatry (2013) 0.87
MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1. Protein Cell (2015) 0.86
MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.86
"Micromanaging" metabolic syndrome. Cell Cycle (2011) 0.86
Complexity of microRNA function and the role of isomiRs in lipid homeostasis. J Lipid Res (2013) 0.86
MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer. Sci Rep (2015) 0.86
Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question. Arterioscler Thromb Vasc Biol (2013) 0.85
Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs. MBio (2015) 0.85
SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression. J Lipid Res (2015) 0.85
miRNA and cholesterol homeostasis. Biochim Biophys Acta (2016) 0.85
Emerging role of microRNAs in lipid metabolism. Acta Pharm Sin B (2015) 0.84
MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment. Mediators Inflamm (2014) 0.84
Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia. J Atheroscler Thromb (2016) 0.83
The emerging role of epigenetics in cardiovascular disease. Ther Adv Chronic Dis (2014) 0.83
Effects of miR-33a-5P on ABCA1/G1-mediated cholesterol efflux under inflammatory stress in THP-1 macrophages. PLoS One (2014) 0.82
microRNA regulation of lipoprotein metabolism. Curr Opin Lipidol (2014) 0.82
A big role for small RNAs in HDL homeostasis. J Lipid Res (2013) 0.82
Noncoding RNAs and atherosclerosis. Curr Atheroscler Rep (2014) 0.82
Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity. Arterioscler Thromb Vasc Biol (2015) 0.82
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell (1997) 17.78
Atherosclerosis. Nature (2000) 15.95
Atherosclerosis. the road ahead. Cell (2001) 11.88
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A (2008) 9.86
MiR-33 contributes to the regulation of cholesterol homeostasis. Science (2010) 6.93
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science (2010) 5.77
LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science (2009) 5.23
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab (2005) 4.79
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A (2000) 4.58
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab (2008) 4.34
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest (2007) 4.20
The LDL receptor. Arterioscler Thromb Vasc Biol (2009) 3.78
Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A (2007) 3.01
Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem (2000) 2.95
ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol (2005) 2.46
The liver X receptor gene team: potential new players in atherosclerosis. Nat Med (2002) 2.24
MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol Immunol (2007) 2.24
MicroRNAs as potential cancer therapeutics. Oncogene (2008) 2.22
ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J Lipid Res (2006) 2.15
MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One (2010) 1.89
MicroRNAs in brain development and physiology. Curr Opin Neurobiol (2009) 1.82
Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy. J Lipid Res (2006) 1.65
High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol (2010) 1.62
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J (2009) 1.59
Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J Lipid Res (2006) 1.52
Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. J Clin Invest (2008) 1.51
Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim Biophys Acta (2006) 1.45
LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol (2002) 1.35
Genomic organization of microRNAs. J Cell Physiol (2010) 1.35
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem (2001) 1.28
Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1. Circ Res (2007) 1.27
Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J Biol Chem (2004) 1.27
The ABCs of sterol transport. J Lipid Res (2008) 1.17
Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice. Arterioscler Thromb Vasc Biol (2006) 1.01
The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation. Atherosclerosis (2007) 1.00
Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A (2003) 6.46
ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab (2005) 4.79
Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res (2006) 3.64
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med (2010) 3.42
Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One (2009) 2.90
Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res (2004) 2.50
Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab (2011) 2.16
A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res (2011) 1.76
A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation. J Biol Chem (2006) 1.73
NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. J Biol Chem (2003) 1.69
Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A (2006) 1.62
Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle (2012) 1.60
A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell (2005) 1.55
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med (2012) 1.54
Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. J Clin Invest (2008) 1.51
Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding. J Biol Chem (2008) 1.45
Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab (2013) 1.42
Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J Rare Dis (2013) 1.33
The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol. J Biol Chem (2005) 1.33
Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem (2007) 1.30
Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes. J Lipid Res (2005) 1.28
Emerging new paradigms for ABCG transporters. Biochim Biophys Acta (2009) 1.26
Genetic screening for Niemann-Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Hum Mol Genet (2013) 1.24
δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders. J Biol Chem (2012) 1.23
Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. Rapid Commun Mass Spectrom (2007) 1.21
Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease. Curr Top Med Chem (2014) 1.19
Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions. J Biol Chem (2008) 1.17
The non-coding RNA gadd7 is a regulator of lipid-induced oxidative and endoplasmic reticulum stress. J Biol Chem (2009) 1.13
Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. Hum Mol Genet (2012) 1.10
Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. J Biol Chem (2012) 1.08
Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling. J Lipid Res (2013) 1.07
Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J Biol Chem (2004) 1.06
25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes. Biophys J (2011) 0.99
Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. Am J Respir Crit Care Med (2015) 0.95
Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker. J Clin Invest (2014) 0.92
Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy. Mol Genet Metab (2012) 0.90
Oxysterols as non-genomic regulators of cholesterol homeostasis. Trends Endocrinol Metab (2012) 0.89
Oligomerization of the murine fatty acid transport protein 1. J Biol Chem (2003) 0.89
Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. J Biol Chem (2011) 0.88
The structural basis of cholesterol accessibility in membranes. Biophys J (2013) 0.86
Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture. J Lipid Res (2013) 0.86
Cholesterol efflux analyses using stable isotopes and mass spectrometry. Anal Biochem (2012) 0.85
Side-chain oxysterols: from cells to membranes to molecules. Biochim Biophys Acta (2011) 0.83
SmD3 regulates intronic noncoding RNA biogenesis. Mol Cell Biol (2012) 0.83
Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1. Hum Mol Genet (2013) 0.83
The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking. J Lipid Res (2003) 0.82
Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids. J Hepatol (2013) 0.82
Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein. Arterioscler Thromb Vasc Biol (2012) 0.80
Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. Blood (2013) 0.79
Box C/D small nucleolar RNA (snoRNA) U60 regulates intracellular cholesterol trafficking. J Biol Chem (2013) 0.79
Side-chain oxysterols modulate cholesterol accessibility through membrane remodeling. Biochemistry (2014) 0.79
Quest for new biomarkers in atherosclerosis. Mo Med (2013) 0.79
Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma. Anal Bioanal Chem (2013) 0.79
Tracking the subcellular fate of 20(s)-hydroxycholesterol with click chemistry reveals a transport pathway to the Golgi. J Biol Chem (2014) 0.79
Chicken ovalbumin upstream promoter-transcription factor I represses the transcriptional activity of the human muscle glycogen phosphorylase promoter in C2C12 cells. Biochim Biophys Acta (2004) 0.78
Altered transition metal homeostasis in Niemann-Pick disease, type C1. Metallomics (2013) 0.76
Synthesis of the enantiomer of the oxysterol-antagonist LY295427. Steroids (2011) 0.76
Rpl13a small nucleolar RNAs regulate systemic glucose metabolism. J Clin Invest (2016) 0.75